Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

215 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Detection of Ebola virus envelope using monoclonal and polyclonal antibodies in ELISA, surface plasmon resonance and a quartz crystal microbalance immunosensor.
Yu JS, Liao HX, Gerdon AE, Huffman B, Scearce RM, McAdams M, Alam SM, Popernack PM, Sullivan NJ, Wright D, Cliffel DE, Nabel GJ, Haynes BF. Yu JS, et al. Among authors: huffman b. J Virol Methods. 2006 Nov;137(2):219-28. doi: 10.1016/j.jviromet.2006.06.014. Epub 2006 Jul 20. J Virol Methods. 2006. PMID: 16857271
Nanoparticle-based biologic mimetics.
Cliffel DE, Turner BN, Huffman BJ. Cliffel DE, et al. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2009 Jan-Feb;1(1):47-59. doi: 10.1002/wnan.20. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2009. PMID: 20049778 Free PMC article. Review.
In vivo testing for gold nanoparticle toxicity.
Simpson CA, Huffman BJ, Cliffel DE. Simpson CA, et al. Methods Mol Biol. 2013;1026:175-86. doi: 10.1007/978-1-62703-468-5_14. Methods Mol Biol. 2013. PMID: 23749578
Circulating Tumor DNA as a Prognostic Biomarker for Recurrence in Patients With Locoregional Esophagogastric Cancers With a Pathologic Complete Response.
Lander EM, Aushev VN, Huffman BM, Hanna D, Dutta P, Ferguson J, Sharma S, Jurdi A, Liu MC, Eng C, Klempner SJ, Gibson MK. Lander EM, et al. Among authors: huffman bm. JCO Precis Oncol. 2024 Dec;8:e2400288. doi: 10.1200/PO.24.00288. Epub 2024 Dec 6. JCO Precis Oncol. 2024. PMID: 39642325 Free PMC article.
GLP-1-Based Therapies Do Not Interfere With Blood Glucose Monitoring Systems.
Mader JK, Huffman B, Sharon R, Bucklar G, Roetschke J. Mader JK, et al. Among authors: huffman b. J Diabetes Sci Technol. 2024 Oct 28:19322968241293810. doi: 10.1177/19322968241293810. Online ahead of print. J Diabetes Sci Technol. 2024. PMID: 39465558 Free PMC article. No abstract available.
A Phase 1 Trial of Trebananib, an Angiopoietin 1 and 2 Neutralizing Peptibody, Combined with Pembrolizumab in Patients with Advanced Ovarian and Colorectal Cancer.
Huffman BM, Rahma OE, Tyan K, Li YY, Giobbie-Hurder A, Schlechter BL, Bockorny B, Manos MP, Cherniack AD, Baginska J, Mariño-Enríquez A, Kao KZ, Maloney AK, Ferro A, Kelland S, Ng K, Singh H, Welsh EL, Pfaff KL, Giannakis M, Rodig SJ, Hodi FS, Cleary JM. Huffman BM, et al. Cancer Immunol Res. 2024 Sep 30. doi: 10.1158/2326-6066.CIR-23-1027. Online ahead of print. Cancer Immunol Res. 2024. PMID: 39348472
215 results